- Home
- BCLI vs MRIN Comparison
BCLI vs MRIN Comparison
Compare BCLI & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MRIN
- Stock Information
- Founded
- BCLI 2000
- MRIN 2006
- Country
- BCLI United States
- MRIN United States
- Employees
- BCLI N/A
- MRIN N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MRIN EDP Services
- Sector
- BCLI Health Care
- MRIN Technology
- Exchange
- BCLI Nasdaq
- MRIN Nasdaq
- Market Cap
- BCLI 6.4M
- MRIN 6.4M
- IPO Year
- BCLI N/A
- MRIN 2013
- Fundamental
- Price
- BCLI $1.21
- MRIN $2.04
- Analyst Decision
- BCLI Strong Buy
- MRIN
- Analyst Count
- BCLI 1
- MRIN 0
- Target Price
- BCLI $30.00
- MRIN N/A
- AVG Volume (30 Days)
- BCLI 118.2K
- MRIN 18.2K
- Earning Date
- BCLI 11-14-2024
- MRIN 10-31-2024
- Dividend Yield
- BCLI N/A
- MRIN N/A
- EPS Growth
- BCLI N/A
- MRIN N/A
- EPS
- BCLI N/A
- MRIN N/A
- Revenue
- BCLI N/A
- MRIN $16,707,999.00
- Revenue This Year
- BCLI N/A
- MRIN N/A
- Revenue Next Year
- BCLI N/A
- MRIN N/A
- P/E Ratio
- BCLI N/A
- MRIN N/A
- Revenue Growth
- BCLI N/A
- MRIN N/A
- 52 Week Low
- BCLI $1.05
- MRIN $1.44
- 52 Week High
- BCLI $11.85
- MRIN $5.46
- Technical
- Relative Strength Index (RSI)
- BCLI 23.69
- MRIN 40.48
- Support Level
- BCLI $1.05
- MRIN $2.04
- Resistance Level
- BCLI $1.95
- MRIN $2.17
- Average True Range (ATR)
- BCLI 0.20
- MRIN 0.08
- MACD
- BCLI -0.00
- MRIN -0.00
- Stochastic Oscillator
- BCLI 15.84
- MRIN 11.82
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MRIN Marin Software Incorporated
Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.